Summary
A 36-year-old defense contractor was granted a security clearance despite concerns under Guideline H (Drug Involvement). The applicant had illegally used his wife's prescribed Vicodin approximately 20 times between June 2013 and April 2014 to manage ankle pain following surgeries. He had previously been prescribed the same medication by his own physician.
The applicant fully disclosed this drug use in his security clearance application and during an investigative interview. The judge found that the applicant's actions mitigated the security concerns.
Key mitigating factors included his complete honesty in disclosing the use, the fact that he used the medication for pain relief after surgeries, and the absence of any evidence of criminal conduct related to drug use. Furthermore, he has not used illegal drugs since April 2014. Based on these factors, the applicant was granted eligibility for access to classified information.
Why the Applicant Prevailed
- The applicant disclosed his illegal drug use in his security clearance application and during an investigative interview.
- He used the medication to alleviate pain after surgeries and had previously been prescribed the same drug.
- There is no evidence of criminal conduct related to drug use, and he has not used illegal drugs since April 2014.
Conditions Referenced
- AG ¶ 25(a)raisedAny Drug Abuse
- AG ¶ 26(a)appliedBehavior Happened so Long Ago, Was Infrequent, or Unlikely to Recur
- AG ¶ 26(b)appliedDemonstrated Intent Not to Abuse Drugs in the Future
- AG ¶ 26(c)appliedAbuse of Prescription Drugs Was After a Severe or Prolonged Illness
- AG ¶ 26(d)rejectedSatisfactory Completion of a Prescribed Drug Treatment ProgramThe applicant did not participate in a substance abuse treatment program.
Key Rule Quoted
“The protection of the national security is the paramount consideration.”
Procedural Posture
- SOR issuedAug 7, 2015
- Answer filedSep 1, 2015Applicant elected to have the case decided on the written record.
- Hearing held—No hearing; case decided on written record.
- Decision dateFeb 10, 2016
Cite For
- Mitigation of Drug Involvement Under Guideline H
- Importance of Full Disclosure in Security Clearance Applications
- Consideration of the Whole-person Concept in Adjudication